EXCLUSIVE: TrumpRx expands to generics; Sen. Tom Cotton calls move a “huge deal” for lowering costs for Arkansans
Screenshot
President Donald Trump is dramatically expanding TrumpRx to include more than 600 generic medications, a move the White House says is aimed at lowering prescription costs for Americans who rely on everyday medicines like cholesterol drugs, diabetes treatments, and blood pressure medications.
The expansion is one of the largest changes to the program since launch. According to Reuters, the updated TrumpRx platform will now include generic medications through partnerships with companies including Amazon Pharmacy, GoodRx, and Mark Cuban’s Cost Plus Drugs.
The White House said the new system will allow consumers to compare pharmacy pricing and delivery options directly through TrumpRx.gov by cutting out middlemen. In a White House fact sheet, the administration said generic drugs account for more than 90 percent of prescriptions dispensed in the United States.
Sen. Tom Cotton (R-Ark.) praised the move in a recent X post, calling the expansion a “huge deal” for lowering drug prices and affordability.
The expansion could have a substantial impact in Arkansas, where many seniors and rely heavily on prescriptions for chronic conditions. Drugs reportedly being added to the platform include common medications such as atorvastatin and metformin.
Reuters reported the administration believes adding generics is critical if TrumpRx is going to reach a broader group of consumers.
Republicans have increasingly highlighted TrumpRx as a major affordability initiative. The Washington Reporter has previously covered growing GOP support for the program, including comments from Rep. Mike Haridopolos (R-Fla.) calling TrumpRx a “huge play” to reduce costs for consumers.
The administration has framed the initiative as part of a broader affordability agenda focused on lowering everyday costs through market competition, pricing transparency, and negotiated deals with industry. The White House says consumers using the platform will be able to compare prices across providers instead of navigating opaque pharmacy pricing systems.
